Bavarian Nordic has initiated two Phase III clinical trials of its mpox vaccine, Jynneos, in pregnant and breastfeeding women ...

First studies to evaluate MVA-BN in infants under 2 years of age and pregnant and breastfeeding women.The multi-partner research project is aimed at expanding access to mpox vaccines for vulnerable ...

First studies to evaluate MVA-BN in infants under 2 years of age and pregnant and breastfeeding women.The multi-partner ...

Danish vaccine specialist Bavarian Nordic (OMX: BAVA) is set to collect $160 million from the sale of a US priority review ...

Clinical trials of Jynneos have begun or will begin soon in infants and children 2 years old and younger, and in pregnant or ...

Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...

Researchers have provided more evidence that mpox virus can be passed from a pregnant mother to her child. There remain ...

More measles cases have been reported in Washington state. Officials in Seattle-King County yesterday reported two measles ...

Check out our BAVA stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Ireland has reported the first case anywhere of mpox in a fully vaccinated person, despite having a high immune response at ...

A high-level overview of Bavarian Nordic A/S (BVNRY) stock. View (BVNRY) real-time stock price, chart, news, analysis, analyst reviews and more.